ESLD

(redirected from End Stage Liver Disease)
AcronymDefinition
ESLDEnd Stage Liver Disease
ESLDEuropean Society for Laser Dermatology (Bassum, Germany)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Progressive familial intrahepatic cholestasis (PFIC) is one of the causes of childhood end stage liver disease.It is an autosomal recessive disorder, characterized by pruritus, coagulopathy, growth retardation, jaundice, and subsequently cirrhosis and hepatic failure due to impaired bile acid transport and metabolism.1 In United States the estimated incidence of progressive intrahepatic cholestasis is 1:50,000 to 1:100,000 births.2 It is classified into three types.
Abbreviations ADPKD: Autosomal dominant polycystic kidney disease ADPLD: Autosomal dominant polycystic liver disease CLF: Chronic liver failure HA: Hepatic artery IVC: Inferior vena cava MELD: Model for end stage liver disease OLT: Orthotopic liver transplant PLD: Polycystic liver disease PV: Portal vein RHV: Right hepatic vein.
There have been several models of classification and staging of CHC, some of which focus on the end stage liver disease for selecting patients for liver transplant19.
Selection an optimal prognostic system for liver cirrhosis: the model for end stage liver disease and beyond.
A model to predict survival in patients with end stage liver disease. Hepatology 2001;33:464.
Frequencies were calculated from the categorical data, i.e., gender, normal or deranged INR, Types of Viral Hepatitis, King's College Criteria and Model for End stage Liver Disease and the number of patients who died during hospitalization.
He said country's budget is insufficient to take care of these end stage liver disease patients and there are no existing transplant facilities in the country.
A Health Protection Agency annual report into the infectious disease revealed there has been an increase in hospital admissions and deaths for End Stage Liver Disease and liver cancer - both of which are related to hepatitis C.
This human study also showed that oral supplementation of bioenhanced palm tocotrienol complex significantly lowers the Model for End Stage Liver Disease (MELD) Score in end stage liver disease patients, compared to the control which was supplemented with tocopherol (the regular form of Vitamin E).
The company said it decided to examine the possibility of testing its cardiac stem cell treatment offshore in light of progress toward its trial of UMK-121, its stem cell treatment for patients awaiting a liver transplant to overcome End Stage Liver Disease (ESLD), in the US.
18 October 2011 - Proteonomix Inc (OTC:PROT) said on Monday that it will examine the possibility to license its technology based on the use of stem cell against diabetes to another company after achieving continued progress towards a trial of UMK-121, a stem cell treatment for patients awaiting liver transplant to overcome End Stage Liver Disease (ESLD).